5,0
19 set 2025
Ex dipendente, più di 3 anni
Cambridge, MA
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
transparency embraced corporate values of fellowship and humility great people and teams
Svantaggi
no longer operating despite success in running clinical trials with complex cell therapies, ran out of runway, couldn't raise money in poor biotech environment